Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DML2B04)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
DIOXINODEHYDROECKOL; Eckstolonol; UNII-N5P71K0GE3; CHEMBL559870; N5P71K0GE3; CHEBI:65820; 5,8,13,14-tetraoxa-pentaphene-1,3,6,9,11-pentol; [1,4]benzodioxino[2,3-a]oxanthrene-1,3,6,9,11-pentol; SCHEMBL14848420; BDBM50319629; 5,8,13,14-Tetraoxa-pentaphene-1,3,6,9,11-pentaol; Benzo(1,2-b:3,4-b')bis(1,4)benzodioxin-1,3,6,9,11-pentol
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||